LIWANLI Innovation Co Ltd (3054.TW) stock: key figures, P/E, revenue and dividend

Information Technology · Technology Hardware, Storage & Peripherals · Taiwan · ISIN TW0003054003

Price
55.80 TWD
Market cap
4.50 bn TWD
P/E (2025)
28.47
P/S (2025)
35.86
Dividend yield
1.43 %
Net margin
125.97 %
Return on equity (ROE)
14.97 %
Return on assets (ROA)
13.85 %

LIWANLI Innovation Co Ltd financials

Fiscal year20242025
Revenue99.16 m TWD125.54 m TWD
Gross profit20.83 m TWD39.11 m TWD
Operating income-37.79 m TWD-70.83 m TWD
EBIT-30.39 m TWD-70.83 m TWD
Net income-32.07 m TWD158.15 m TWD
Diluted EPS – continuing operations-0.40 TWD1.96 TWD

Full history since 2003, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About LIWANLI Innovation Co Ltd

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is headquartered in Taipei, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.